Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
D035843:Biomedical Research; D002648:Child; D003219:Confidentiality; D016265:Conflict of Interest; D004345:Drug Industry; D004467:Economics; D035082:Federal Government; D005378:Financial Support; D005380:Financing, Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D033181:Information Dissemination; D007255:Information Services; D009316:National Institutes of Health (U.S.); D011640:Public Policy; D012106:Research; D012108:Research Personnel; D012926:Social Control, Formal; D036302:Therapeutic Human Experimentation; D014481:United States; D014495:Universities
Biomedical and Behavioral Research; Genetic Therapy Inc.; Genetics and Reproduction; National Institutes of Health; Popular Approach/Source